These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 24561416)

  • 1. Interleukin 6 blockade for hyperimmunoglobulin D and periodic fever syndrome.
    Shendi HM; Devlin LA; Edgar JD
    J Clin Rheumatol; 2014 Mar; 20(2):103-5. PubMed ID: 24561416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Etanercept and anakinra can prolong febrile episodes in patients with hyperimmunoglobulin D and periodic fever syndrome.
    Shendi HM; Walsh D; Edgar JD
    Rheumatol Int; 2012 Jan; 32(1):249-51. PubMed ID: 20020131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term efficacy of canakinumab in hyperimmunoglobulin D syndrome.
    Ozdemir Isik O; Karadag DT; Tekeoglu S; Yazici A; Cefle K; Cefle A
    Int J Rheum Dis; 2024 Jan; 27(1):e14857. PubMed ID: 37578023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperimmunoglobulinemia D and periodic fever syndrome; treatment with etanercept and follow-up.
    Topaloğlu R; Ayaz NA; Waterham HR; Yüce A; Gumruk F; Sanal O
    Clin Rheumatol; 2008 Oct; 27(10):1317-20. PubMed ID: 18506569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperimmunoglobulin D syndrome in childhood.
    van der Hilst JC; Frenkel J
    Curr Rheumatol Rep; 2010 Apr; 12(2):101-7. PubMed ID: 20425018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term follow-up, clinical features, and quality of life in a series of 103 patients with hyperimmunoglobulinemia D syndrome.
    van der Hilst JCH; Bodar EJ; Barron KS; Frenkel J; Drenth JPH; van der Meer JWM; Simon A;
    Medicine (Baltimore); 2008 Nov; 87(6):301-310. PubMed ID: 19011501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. On-demand anakinra treatment is effective in mevalonate kinase deficiency.
    Bodar EJ; Kuijk LM; Drenth JP; van der Meer JW; Simon A; Frenkel J
    Ann Rheum Dis; 2011 Dec; 70(12):2155-8. PubMed ID: 21859689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperimmunoglobulinemia D and periodic fever syndrome in children. Review on therapy with biological drugs and case report.
    Korppi M; Van Gijn ME; Antila K
    Acta Paediatr; 2011 Jan; 100(1):21-5. PubMed ID: 20712835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of hyperimmunoglobulinemia D syndrome with biologics in children: review of the literature and Finnish experience.
    Kostjukovits S; Kalliokoski L; Antila K; Korppi M
    Eur J Pediatr; 2015 Jun; 174(6):707-14. PubMed ID: 25721923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Canakinumab for the treatment of hyperimmunoglobulin D syndrome.
    Sánchez-Manubens J; Iglesias E; Anton J
    Expert Rev Clin Immunol; 2019 Mar; 15(3):215-220. PubMed ID: 30652926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of interleukin-6 in a patient with tumor necrosis factor receptor-associated periodic syndrome: assessment of outcomes following treatment with the anti-interleukin-6 receptor monoclonal antibody tocilizumab.
    Vaitla PM; Radford PM; Tighe PJ; Powell RJ; McDermott EM; Todd I; Drewe E
    Arthritis Rheum; 2011 Apr; 63(4):1151-5. PubMed ID: 21225679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. International Retrospective Chart Review of Treatment Patterns in Severe Familial Mediterranean Fever, Tumor Necrosis Factor Receptor-Associated Periodic Syndrome, and Mevalonate Kinase Deficiency/Hyperimmunoglobulinemia D Syndrome.
    Ozen S; Kuemmerle-Deschner JB; Cimaz R; Livneh A; Quartier P; Kone-Paut I; Zeft A; Spalding S; Gul A; Hentgen V; Savic S; Foeldvari I; Frenkel J; Cantarini L; Patel D; Weiss J; Marinsek N; Degun R; Lomax KG; Lachmann HJ
    Arthritis Care Res (Hoboken); 2017 Apr; 69(4):578-586. PubMed ID: 27723279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment with anakinra in the hyperimmunoglobulinemia D/periodic fever syndrome.
    Rigante D; Ansuini V; Bertoni B; Pugliese AL; Avallone L; Federico G; Stabile A
    Rheumatol Int; 2006 Nov; 27(1):97-100. PubMed ID: 16871408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monogenic Periodic Fever Syndromes: Treatment Options for the Pediatric Patient.
    Ozen S; Demir S
    Paediatr Drugs; 2017 Aug; 19(4):303-311. PubMed ID: 28497352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reasons for canakinumab initiation among patients with periodic fever syndromes: a retrospective medical chart review from the United States.
    Hur P; Lomax KG; Ionescu-Ittu R; Manceur AM; Xie J; Cammarota J; Gautam R; Sanghera N; Kim N; Grom AA
    Pediatr Rheumatol Online J; 2021 Sep; 19(1):143. PubMed ID: 34521444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systematic literature review of efficacy/effectiveness and safety of current therapies for the treatment of cryopyrin-associated periodic syndrome, hyperimmunoglobulin D syndrome and tumour necrosis factor receptor-associated periodic syndrome.
    Kuemmerle-Deschner JB; Gautam R; George AT; Raza S; Lomax KG; Hur P
    RMD Open; 2020 Jul; 6(2):. PubMed ID: 32723831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-interleukin 1 treatment for patients with familial Mediterranean fever resistant to colchicine.
    Ozen S; Bilginer Y; Aktay Ayaz N; Calguneri M
    J Rheumatol; 2011 Mar; 38(3):516-8. PubMed ID: 21159830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advances in the diagnosis and treatment of tumor necrosis factor receptor-associated periodic syndrome.
    Aguado-Gil L; Irarrazaval-Armendáriz I; Pretel-Irazabal M
    Actas Dermosifiliogr; 2013 Sep; 104(7):617-22. PubMed ID: 23891452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Consensus protocols for the diagnosis and management of the hereditary autoinflammatory syndromes CAPS, TRAPS and MKD/HIDS: a German PRO-KIND initiative.
    Hansmann S; Lainka E; Horneff G; Holzinger D; Rieber N; Jansson AF; Rösen-Wolff A; Erbis G; Prelog M; Brunner J; Benseler SM; Kuemmerle-Deschner JB
    Pediatr Rheumatol Online J; 2020 Feb; 18(1):17. PubMed ID: 32066461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TLR2/TLR4-dependent exaggerated cytokine production in hyperimmunoglobulinaemia D and periodic fever syndrome.
    Stoffels M; Jongekrijg J; Remijn T; Kok N; van der Meer JW; Simon A
    Rheumatology (Oxford); 2015 Feb; 54(2):363-8. PubMed ID: 25173351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.